LBPH News

A total of 32 companies entered the public market this past week, with the week’s 7 IPOs joined by one direct listing and 24 SPACs. In the largest US IPO of the year to date, Coupang (CPNG) upsized and priced above the upwardly revised range to raise $4.6 billion at a $62.9 billion market cap. The largest e-commerce player in Korea, Coupang nearly...read more

Longboard Pharmaceuticals, a Phase 1 biotech formed by Arena Pharmaceuticals developing medicines for neurological diseases, raised $80 million by offering 5 million shares at $16, the high end of the range of $14 to $16. Longboard Pharmaceuticals is focused on developing novel, transformative medicines for neurological diseases. It was formed in January 2020 by Arena...read more

Longboard Pharmaceuticals, a Phase 1 biotech formed by Arena Pharmaceuticals developing medicines for neurological diseases, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Longboard Pharmaceuticals would command a fully diluted...read more

Updated Monday, 3/8. Seven IPOs and one direct listing are currently scheduled for the week ahead. Korean e-commerce giant Coupang (CPNG) plans to raise $3.4 billion at a $51.0 billion market cap. A leading player in its market, the company nearly doubled revenue in 2020 and has expanded its margins in recent years. Coupang is unprofitable, and...read more